Thirteen top drug companies joined efforts to fight antimicrobial resistance by vowing to reduce pollution emitted from antibiotic factories, according to a statement released on Tuesday.
Both generic and brand-name drugmakers are involved with the initiative, including Pfizer, Merck, Novartis, GlaxoSmithKline, Johnson & Johnson, Sanofi and AstraZeneca.
In the statement, the drugmakers highlight key actions they will take to reduce the threat of AMR. The group promises to set new factory standards and review supply chain practices to make sure antibiotic waste does not reach waterways, as well as help ensure antibiotics are used only for patients who need them, among other initiatives.
The announcement comes just one day before the U.N. General Assembly's high-level meeting on antimicrobial resistance will be held in New York.
More articles on supply chain:
4 things to know about generic price spikes
J&J to acquire Abbott's eye surgery unit: 5 things to know
Valeant defends drug discount program for two heart drugs